CVintra result of outlier [Study As­sess­ment]

posted by Dr_Dan  – Germany, 2013-04-26 10:58 (4808 d 07:37 ago) – Posting: # 10498
Views: 5,471

Hi jag009,
as far as I understood the subject completed two reference treatments, one with detectable drug concentrations and one without = no profile. You could argue that the reference product is of such a poor quality that inclusion of the period without profile would on the one side affect the comparison with the test product in a negative way and on the other side would give a wrong impression on the intra-individual variability of the reference product. According to EMA guideline:
“The applicant should justify that the calculated intra-subject variability is a reliable estimate and that it is not the result of outliers.”
Maybe this helps.
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
142 visitors (0 registered, 142 guests [including 22 identified bots]).
Forum time: 18:35 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5